What is Daré Bioscience?
Daré Bioscience operates as a clinical-stage biopharmaceutical entity dedicated to the advancement of innovative therapeutic solutions tailored for women's health. The organization focuses on identifying and developing a diverse portfolio of differentiated products that address critical gaps in contraception, vaginal health, sexual health, and fertility. By prioritizing therapies that improve clinical outcomes and facilitate patient convenience, Daré Bioscience occupies a specialized niche in the life sciences market, aiming to expand treatment options through rigorous scientific validation and strategic commercialization efforts.
How much funding has Daré Bioscience raised?
Daré Bioscience has raised a total of $36.6M across 5 funding rounds:
Multiple Rounds
$22.1M
Other Financing Round
$12M
Grant
$2.5M
Share Placement (2020): $6.8M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Share Placement (2020): $15M supported by Lincoln Park Capital Fund , LLC
Other Financing Round (2023): $12M, investors not publicly disclosed
Grant (2024): $2.5M, investors not publicly disclosed
Key Investors in Daré Bioscience
Lincoln Park Capital Fund, LLC
A Chicago-based institutional investment firm specializing in structured equity financing for growth-stage companies.
PPP
Public-Private Partnership
Undisclosed Investors
What's next for Daré Bioscience?
With the recent influx of capital, Daré Bioscience is well-positioned to accelerate its clinical development programs and navigate the complex regulatory landscape inherent to the biopharmaceutical industry. The company's strategic roadmap likely involves scaling its core therapeutic assets toward late-stage trials and potential market entry. As the firm continues to refine its portfolio, the focus will remain on achieving key clinical milestones that validate its proprietary technology. Investors and stakeholders will be monitoring the company's ability to translate this financial momentum into tangible therapeutic breakthroughs, which are essential for long-term value creation in the competitive women's health sector.
See full Daré Bioscience company page
